Abstract
Relevance. If we reduce the treatment exclusively to the eradication of Helicobacter pylori (Hp), the question of monitoring the results of anti-Hp therapy is controversial, given the widely known data on the detection of Hp, including virulent strains of Hp, in most healthy individuals.The aim of the study: to track the dynamics of stomach colonization with various Hp strains in patients with gastric ulcer and duodenal ulcer (PUD) immediately after the use of standard three-component anti-Hp therapy (AHT) and 1.5–2 months after AHT.Methods. Genotyping of Hp strains was carried out by the VNTR method together with the determination of the cagA gene.Results. Assessment of the results of AHT in the form of «eradication of Hp — re-detection of Hp» (i. e., without taking the determination of Hp strains into account) showed less reliability in the differences than the «eradication — preservation of the strain or change of the strain» score in patients with PUD; in addition, the differences between the initial bacteriological picture and that observed immediately after AHT were on the verge of reliability, while the differences between the initial bacteriological picture and that observed after 1.5–2 months had a high degree of reliability. The number of eradications increased (eradication achieved immediately after AHT was not preserved, except for one) and the number of cagA-containing strains decreased (due to new eradication detected at late follow-up periods and due to a change in strains) in long-term follow-up in patients with PUD.Conclusion. Since all patients with PUD achieved clinical remission, which lasted for the next 1.5–2 months, the success of AHT should not be unambiguously associated with the eradication of Hp; the restoration of the organism's colonization resistance to Hp after a course of therapy is more likely.
Highlights
КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ И ПРАКТИКА patients with PUD achieved clinical remission, which lasted for the 1.5–2 months, the success of anti-Hp therapy (AHT) should not be unambiguously associated with the eradication of Helicobacter pylori (Hp); the restoration of the organism's colonization resistance to Hp after a course of therapy is more likely
If we reduce the treatment exclusively to the eradication of Helicobacter pylori (Hp), the question of monitoring the results of anti-Hp therapy is controversial, given the widely known data on the detection of Hp, including virulent strains of Hp, in most healthy individuals
The aim of the study: to track the dynamics of stomach colonization with various Hp strains in patients with gastric ulcer and duodenal ulcer (PUD) immediately after the use of standard three-component anti-Hp therapy (AHT) and 1.5–2 months after AHT
Summary
Поступавшим в стационар больным с язвенным анамнезом и клинической картиной язвенной болезни желудка или язвенной болезни двенадцатиперстной кишки (ЯБ) проводилась эзофагогастродуоденоскопия (ЭГДС) с взятием биопсии и проведением экспресс-теста на наличие Нр; при обнаружении Нр такой больной рассматривался как потенциальный объект нашего исследования, если у больного не было выраженной сопутствующей патологии; рандомизированный подход не ограничивал набор больных по полу и возрасту. После проведения курса антихеликобактерной терапии больному ЯБ проводилось повторное гастроскопическое исследование (как минимум для контроля репаративных процессов в желудке); взятый при этом гастробиоптат являлся вторым исследуемым объектом (II этап исследования). Больные хроническим гастритом (ХГ), отказавшиеся от антихеликобактерной терапии, при отсутствии выраженной сопутствующей патологии включались в контрольную группу; рандомизированный подход не ограничивал набор по полу и возрасту; гастробиоптаты, взятые у больных ХГ, участвовали в I этапе исследования контрольной группы. Results of Hp genotyping from gastro-biopsy specimens in patients with chronic gastritis; comparison of the results of study I (the first EGDS carried out upon admission of the patient with chronic gastritis) and study II (the second EGDS after 1.5–2 months of symptomatic therapy, «on demand», outpatient)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.